Combination therapy

Mar 15, 2018

Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results

Nov 10, 2017

Infinity Pharmaceuticals Reports IPI-549 Clinical and Translational Data from Completed Monotherapy Dose-Escalation Component of Phase 1/1b Clinical Study in Patients with Advanced Solid Tumors at SITC Annual Meeting

Nov 07, 2017

Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results

Oct 23, 2017

US Rheumatologists Report that Use of Biologic/JAK Monotherapy in Rheumatoid Arthritis is Greatest for Pfizer's Xeljanz, Roche/Genentech's Actemra, and Sanofi/Regeneron's Recently Launched Kevzara

Aug 03, 2017

Infinity Provides Company Update and Reports Second Quarter 2017 Financial Results